materialise innovators you can count on Q1 2022 Financial Results Conference Call April 28, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and pros ...

Materialise NV (NASDAQ:MTLS) Q4 2021 Earnings Conference Call March 3, 2022 8:30 AM ET Company Participants Fried Vancraen ??? Founder and Chief Executive Officer Johan Albrecht ??? Chief Financial Officer Peter Leys ??? Executive Chairman Harriet Fried ??? Investor Relations Conference Call Participants Troy Jensen ??? Lake Street Capital Devin Au ??? KeyBanc Capital Markets Noelle Dilts ??? Stifel Gregory Ramirez ??? Bryan Garnier Bhavna Advani ??? JPMorgan Operator Good day. Thank you for standing ...

materialise innovators you can count on Q4 2021 Financial Results Conference Call March 3, 2022 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...

Financial Data and Key Metrics Changes - Materialise reported a record quarterly revenue of EUR52.2 million, representing a 28% increase year-over-year [8][17] - Adjusted EBITDA reached EUR9.739 million, a 62% increase compared to the previous year, with an EBITDA margin of almost 19% [8][18] - Net profit for the quarter was EUR8.652 million, or EUR0.15 per diluted share, compared to a net loss of EUR282,000 in the same period last year [23] Business Line Data and Key Metrics Changes - Software segment revenue increased by 10.4% to EUR10.468 million, with an adjusted EBITDA margin of 35.4% [18][19] - Medical segment revenue grew by 10.2% to EUR18.9 million, with adjusted EBITDA of EUR5.251 million, maintaining a margin of 31.8% [19][20] - Manufacturing segment revenue surged by 61.2% to EUR22.8 million, with an adjusted EBITDA margin of 15.5% [21][22] Market Data and Key Metrics Changes - The automotive market remains unstable due to supply chain disruptions, affecting both European and global operations [29] - The airliner market continues to show weakness, impacting revenue from plastic automotive prototyping [12][29] - Other segments, such as wearables and medical instrumentation, are experiencing growth, offsetting declines in automotive and aerospace [12] Company Strategy and Development Direction - Materialise focuses on meaningful applications in additive manufacturing, aiming to create value for customers while ensuring sustainable growth [11][16] - The company is committed to reducing its carbon footprint, targeting a 50% reduction by 2025, with a 33% reduction achieved by the end of 2021 [16] - Investments are being made in growth initiatives, including CMS, footwear, and eyewear, with expectations for continued growth in these areas [36] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving revenue closer to the higher end of the EUR197 million to EUR200 million range for 2021 [26] - The company plans to gradually increase operational expenses to support growth initiatives, impacting 2022 results more significantly [26] - Management remains cautious about economic uncertainties but believes in the strength of their product offerings and market recovery [33] Other Important Information - The company reported a strong balance sheet with cash amounting to EUR194.9 million, up from EUR111.5 million at the end of the previous year [24] - Deferred revenue totaled EUR35 million, primarily related to annual software sales and maintenance contracts [25] Q&A Session Summary Question: Signs of improvement in the automotive market? - Management noted ongoing instability in the automotive market due to supply chain disruptions, with expectations for this to continue throughout the year [29] Question: Growth drivers in the medical segment? - The growth in the medical segment is attributed to structural growth rather than pent-up demand, with software sales increasing by 15% [30] Question: Clarification on guidance and economic uncertainty? - Management acknowledged economic uncertainty but emphasized their historical approach to providing annual guidance, balancing strong quarterly performance with realistic expectations [33] Question: Update on strategic priorities and investments? - Growth has been reported in CMS, footwear, and eyewear, with significant investments planned for the footwear segment to ensure long-term growth [36] Question: Sustainability of manufacturing margins? - Management indicated that while current margins are strong, manufacturing is a cyclic business, and they prefer to focus on high-end applications rather than overinvesting in capacity [53]

Financial Performance - Q3 2021 revenue increased by 28% year-over-year to 52195 kEUR[6,11] - Q3 2021 Adjusted EBITDA increased by 62% year-over-year to 9739 kEUR[6,15] - Adjusted EBITDA margin increased to 18.7% in Q3 2021[6,15] - Q3 2021 Net result grew to 8652 kEUR, compared to a loss of (282) kEUR in Q3 2020[6] - Earnings per share reached 0.15 EUR-ct in Q3 2021[6] Segment Performance - Materialise Manufacturing revenue rose 61% compared to Q3 2020[13] - Software segment revenue increased by 10.4% year-over-year to 10468 kEUR in Q3 2021[18] - Medical segment revenue rose by 10.2% to 18910 kEUR in Q3 2021[20] - Manufacturing segment revenue increased by 61.2% year-over-year to 22817 kEUR in Q3 2021[23] Financial Position - Cash and equivalents increased to 194946 kEUR as of September 30, 2021, compared to 111538 kEUR at the end of 2020[25] Outlook - The company expects revenue to be at the higher end of the 197 million EUR - 200 million EUR range for 2021[27] - The company is increasing its Adjusted EBITDA guidance by 3 million EUR to up to 28 million EUR for 2021[27]

Financial Data and Key Metrics Changes - Revenues grew 33% to EUR 50.7 million compared to the same period last year, with adjusted EBITDA more than doubling to EUR 6.9 million [9][27] - Compared to Q1 2021, revenues increased by 11.3% and adjusted EBITDA rose by 13% [11] - Compared to Q2 2019, revenues grew by 5% and adjusted EBITDA increased by 37% [12] Business Line Data and Key Metrics Changes - Software segment revenue increased by 5% to EUR 10 million, with a 24% increase in recurrent sales [32] - Medical segment revenue surged over 50% to EUR 17.5 million, with a 21% growth compared to Q2 2019 [34] - Manufacturing segment revenue increased by 39% to EUR 23.3 million, recovering 22% from Q1 2021 [36] Market Data and Key Metrics Changes - The Medical segment accounted for 34% of total revenue, while Manufacturing represented 46% [29] - Deferred revenues from software licenses and maintenance fees increased by EUR 1.7 million compared to the end of last year [28] Company Strategy and Development Direction - The company plans to use newly raised funds to accelerate growth drivers, including the rollout of Magics and Mimics software platforms and expansion in CMF markets [13][14] - The focus remains on 3D printing applications, with no intention to significantly broaden into CNC machining or other conventional manufacturing technologies [64] Management's Comments on Operating Environment and Future Outlook - Management sees a positive but fragile global trend of businesses recovering from the pandemic, expecting revenues for 2021 to exceed 2019 levels, potentially reaching close to EUR 200 million [47][48] - The majority of revenues in the second half of the year are expected to come from a strong fourth quarter [48] Other Important Information - The company moved into a new Metal 3D Printing center in Bremen, Germany, with an official opening planned for October 7th [23] - Cash amounted to EUR 182.8 million at the end of Q2 2021, up from EUR 111.5 million at the end of the previous year [43] Q&A Session Summary Question: How did the recovery in end markets develop through the quarter? - Management noted a positive trend throughout the quarter, with continuous increases in sales in Medical and Software, while the Automotive market remains unstable due to supply chain issues [53] Question: Can the Manufacturing segment exceed 2019 levels? - Management expects Manufacturing to recover but does not anticipate the same revenue mix as in 2019, with Software and Medical becoming more significant parts of overall revenues [55] Question: Thoughts on digital manufacturing and competition? - The company remains focused on 3D printing applications and does not plan to expand significantly into CNC machining or other conventional manufacturing technologies [64] Question: Concerns about new entrants in software competition? - Management respects competition but believes new players face significant hurdles and that the company has a solid base to withstand competitive pressures [67] Question: Expectations for Q3? - Management indicated that Q3 is typically slower, with more growth expected in Q4, aligning with traditional seasonal patterns [69]

materialise innovators you can count on Q2 2021 Financial Results Conference Call July 29, 2021 www.materialise.com NASDAQ: MTLS Safe Harbor Summary This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, our intentions, beliefs, assumptions, projections, outlook, analyses or current expectations, plans, objectives, strategies and prosp ...

Materialise NV (NASDAQ:MTLS) Q1 2021 Earnings Conference Call April 29, 2021 8:30 AM ET Company Representatives Fried Vancraen - Founder, Chief Executive Officer Peter Leys - Executive Chairman Johan Albrecht - Chief Financial Officer Harriet Fried - LHA Conference Call Participants Jason Celino - KeyBanc Troy Jensen - Lake Street Capital Arvind Ramnani - Piper Sandler Operator Hello, ladies and gentlemen and welcome to the Q1, 2021 Materialise Financial Results Conference Call. At this time all participant ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE AC ...

Financial Performance - Q1 2021 revenue was 45554 kEUR, a decrease of 1.5% from Q1 2020[6] - Q1 2021 Adjusted EBITDA grew 48% to 5341 kEUR, representing 11.7% of revenue[6] - Q1 2021 Operating profit grew to 290 kEUR compared to (1084) kEUR in Q1 2020[6] - Q1 2021 Net result was (3667) kEUR compared to (2899) kEUR in Q1 2020[6] Segment Performance - Software segment revenue in Q1 2021 was 10219 kEUR, 4.1% above Q1 2020[19] - Medical segment revenue in Q1 2021 increased 3.7% to 16231 kEUR[23] - Medical segment Adjusted EBITDA grew 85% to 4541 kEUR, resulting in a 28% EBITDA margin[23] - Manufacturing segment revenue decreased 8.2% compared to Q1 2020[27] - Manufacturing segment Adjusted EBITDA amounted to -144 kEUR[27] Other Financial Data - Deferred revenues from software license and maintenance fees grew by 1.9 million EUR from the end of last year[15]